Female Pelvic Conditions: Polycystic Ovary Syndrome

Area of Science:

• Reproductive Endocrinology
• Gynecology
• Metabolic Disorders

Background:

• Polycystic ovary syndrome (PCOS) affects approximately 10% of reproductive-aged women in the US.
• Key risk factors include obesity and a family history of PCOS.
• Diagnosis is considered for irregular menses, hyperandrogenism, or infertility.

Purpose of the Study:

• To outline the diagnostic criteria for PCOS.
• To discuss differential diagnoses for PCOS symptoms.
• To review current treatment strategies for PCOS.

Main Methods:

• Diagnosis relies on the Rotterdam criteria: oligo/anovulation, hyperandrogenism (clinical/biochemical), and polycystic ovaries on ultrasound.
• Laboratory tests exclude other conditions like thyroid disorders and hyperprolactinemia.
• Treatment focuses on lifestyle changes for weight loss and combination oral contraceptives.

Main Results:

• A 5%-10% weight loss significantly reduces PCOS symptoms.
• Combination oral contraceptives offer endometrial protection and manage acne/hirsutism.
• Letrozole is a first-line treatment for PCOS-related anovulation and infertility.

Conclusions:

• PCOS management involves addressing metabolic and reproductive disturbances.
• Lifestyle modifications and pharmacotherapy are crucial for symptom control.
• Further research into long-term PCOS management and off-label treatment efficacy is warranted.